Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Hear from our experts: A retrospective look at past Mycoplasma validation queries and responses
Watch this educational webinar and learn how recent innovation can help you to significantly push the boundaries of viral vectors productivity and quality. Discover how recent innovation in areas such as cells, media and transfection agents can boost and standardise your process, as illustrated by our lentiviral case study.
Watch this webinar and learn more about validation of a qPCR assay for residual host cell DNA quantitation.
Our studies demonstrate that our new CTS Dynabeads Treg Xpander results in superior regulatory T cell (Treg) expansion with maintenance of high %FOXP3 expression after 12-14 days.
The quality of raw materials needs to be considered according to the stage of development of the cell or gene therapy.
Scaling up adherent cell culture can be a difficult process for many vaccine, cell therapy, gene therapy, and viral vector manufacturers. Some cells can alter their properties if they are not cultured in specific conditions.
Adoptive immunotherapy displays immense potential as an immunotherapeutic strategy for patients with advanced malignancies. Phenol red has been a mainstay in media used for the ex vivo expansion of primary T cells.
This article focuses on key regulatory considerations and requirements across the cell and gene therapy raw and starting materials area.
Access a targeted collection of scientific application notes, case studies, posters, white papers and more for bioprocessing: